Works by Pardanani, Animesh

Results: 202
    1

    Multihit TP53 Mutations in Myeloproliferative Neoplasms and Acute Myeloid Leukemia: Comparative Analysis of Survival and Risk Factors in 142 Informative Cases.

    Published in:
    American Journal of Hematology, 2025, v. 100, n. 6, p. 1010, doi. 10.1002/ajh.27670
    By:
    • Fathima, Saubia;
    • Abdelmagid, Maymona;
    • Alsugair, Ali;
    • Begna, Kebede H.;
    • Al‐Kali, Aref;
    • Mangaonkar, Abhishek A.;
    • Pardanani, Animesh D.;
    • Patnaik, Mrinal M.;
    • Zepeda Mendoza, Cinthya J.;
    • He, Rong;
    • Reichard, Kaaren K.;
    • Badar, Talha;
    • Foran, James M.;
    • Palmer, Jeanne;
    • Loscocco, Giuseppe G.;
    • Guglielmelli, Paola;
    • Vannucchi, Alessandro M.;
    • Orazi, Attilio;
    • Arber, Daniel A.;
    • Hiwase, Devendra
    Publication type:
    Article
    2

    Abnormal karyotype is an independent predictor of inferior survival in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN).

    Published in:
    Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00812-y
    By:
    • Abdallah, Mostafa;
    • McCullough, Kristen;
    • Ilyas, Rimal;
    • Begna, Kebede H.;
    • Al-Kali, Aref;
    • Litzow, Mark R.;
    • Hogan, William J.;
    • Mangaonkar, Abhishek;
    • Alkhateeb, Hassan;
    • Shah, Mithun V.;
    • Elliott, Michelle A.;
    • Foran, James M.;
    • Badar, Talha;
    • Palmer, Jeanne M.;
    • Yi, Cecilia Arana;
    • Sproat, Lisa;
    • Pardanani, Animesh;
    • Patnaik, Mrinal M.;
    • Olteanu, Horatiu;
    • Ketterling, Rhett P.
    Publication type:
    Article
    3

    Abnormal karyotype is an independent predictor of inferior survival in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

    Published in:
    2023
    By:
    • Abdallah, Mostafa;
    • McCullough, Kristen;
    • Ilyas, Rimal;
    • Begna, Kebede H.;
    • Al-Kali, Aref;
    • Litzow, Mark R.;
    • Hogan, William J.;
    • Mangaonkar, Abhishek;
    • Alkhateeb, Hassan;
    • Shah, Mithun V.;
    • Elliott, Michelle A.;
    • Foran, James M.;
    • Badar, Talha;
    • Palmer, Jeanne M.;
    • Yi, Cecilia Arana;
    • Sproat, Lisa;
    • Pardanani, Animesh;
    • Patnaik, Mrinal M.;
    • Olteanu, Horatiu;
    • Ketterling, Rhett P.
    Publication type:
    Letter
    4
    5
    6
    7

    Myelodysplastic/myeloproliferative neoplasms with ring sideroblasts and thrombocytosis (MDS/MPN-RS-T): Mayo-Moffitt collaborative study of 158 patients.

    Published in:
    Blood Cancer Journal, 2022, v. 12, n. 2, p. 1, doi. 10.1038/s41408-022-00622-8
    By:
    • Mangaonkar, Abhishek A.;
    • Lasho, Terra L.;
    • Ketterling, Rhett P.;
    • Reichard, Kaaren K.;
    • Gangat, Naseema;
    • Al-Kali, Aref;
    • Begna, Kebede H.;
    • Pardanani, Animesh;
    • Al Ali, Najla H.;
    • Talati, Chetasi;
    • Sallman, David;
    • Padron, Eric;
    • Patnaik, Mrinal M.;
    • Tefferi, Ayalew;
    • Komrokji, Rami
    Publication type:
    Article
    8
    9

    Mutations and thrombosis in essential thrombocythemia.

    Published in:
    2021
    By:
    • Guglielmelli, Paola;
    • Gangat, Naseema;
    • Coltro, Giacomo;
    • Lasho, Terra L.;
    • Loscocco, Giuseppe Gaetano;
    • Finke, Christy M.;
    • Morsia, Erika;
    • Sordi, Benedetta;
    • Szuber, Natasha;
    • Hanson, Curtis A.;
    • Pardanani, Animesh;
    • Vannucchi, Alessandro M.;
    • Tefferi, Ayalew
    Publication type:
    Letter
    10
    11

    Mayo Clinic experience with 1123 adults with acute myeloid leukemia.

    Published in:
    Blood Cancer Journal, 2021, v. 11, n. 3, p. 1, doi. 10.1038/s41408-021-00435-1
    By:
    • Begna, Kebede H.;
    • Ali, Walid;
    • Naseema Gangat;
    • Elliott, Michelle A.;
    • Al-Kali, Aref;
    • Litzow, Mark R.;
    • Christopher Hook, C.;
    • Wolanskyj-Spinner, Alexandra P.;
    • Hogan, William J.;
    • Patnaik, Mrinal M.;
    • Pardanani, Animesh;
    • Zblewski, Darci L.;
    • Chen, Dong;
    • He, Rong;
    • Viswanatha, David;
    • Hanson, Curtis A.;
    • Ketterling, Rhett P.;
    • Tefferi, Ayalew
    Publication type:
    Article
    12

    A population-based study of chronic neutrophilic leukemia in the United States.

    Published in:
    2020
    By:
    • Ruan, Gordon J.;
    • Smith, Caleb J.;
    • Day, Courtney;
    • Harmsen, William S.;
    • Zblewski, Darci L.;
    • Alkhateeb, Hassan;
    • Begna, Kebede;
    • Al-Kali, Aref;
    • Litzow, Mark R.;
    • Hogan, William;
    • Szuber, Natasha;
    • Gangat, Naseema;
    • Patnaik, Mrinal S.;
    • Pardanani, Animesh;
    • Elliott, Michelle A.;
    • Tefferi, Ayalew;
    • Go, Ronald S.;
    • Shah, Mithun V.
    Publication type:
    Letter
    13

    When and how to transplant in myelofibrosis – recent trends.

    Published in:
    Leukemia & Lymphoma, 2025, v. 66, n. 3, p. 359, doi. 10.1080/10428194.2024.2422835
    By:
    • Sharma, Naman;
    • Loscocco, Giuseppe G.;
    • Gangat, Naseema;
    • Guglielmelli, Paola;
    • Pardanani, Animesh;
    • Vannucchi, Alessandro M.;
    • Alkhateeb, Hassan B.;
    • Tefferi, Ayalew;
    • Ho, Vincent T.
    Publication type:
    Article
    14

    Clinical outcomes of adults with hemophagocytic lymphohistiocytosis treated with the HLH-04 protocol: a retrospective analysis.

    Published in:
    Leukemia & Lymphoma, 2020, v. 61, n. 7, p. 1592, doi. 10.1080/10428194.2020.1737684
    By:
    • Bubik, Rachel J.;
    • Barth, Dylan M.;
    • Hook, Christopher;
    • Wolf, Robert C.;
    • Muth, Jessica M.;
    • Mara, Kristin;
    • Patnaik, Mrinal S.;
    • Pruthi, Rajiv K.;
    • Marshall, Ariela L.;
    • Litzow, Mark R.;
    • Elliott, Michelle A.;
    • Hogan, William J.;
    • Shah, Mithun V.;
    • Begna, Kebede H.;
    • Alkhateeb, Hassan;
    • Pardanani, Animesh;
    • Ashrani, Aneel A.;
    • Call, Timothy G.;
    • Rivera, Candido E.;
    • Camoriano, John K.
    Publication type:
    Article
    15
    16
    17

    Not all CALR mutations are created equal.

    Published in:
    2015
    By:
    • He, Rong;
    • Hanson, Curtis A.;
    • Chen, Dong;
    • Oliveira, Jennifer L.;
    • Pardanani, Animesh;
    • Reichard, Kaaren K.;
    • Viswanatha, David S.
    Publication type:
    Letter to the Editor
    18
    19
    20

    Comparison of complication rates of Hickman<sup>®</sup> catheters versus peripherally inserted central catheters in patients with acute myeloid leukemia undergoing induction chemotherapy.

    Published in:
    Leukemia & Lymphoma, 2013, v. 54, n. 6, p. 1263, doi. 10.3109/10428194.2012.742520
    By:
    • Lim, Ming Y.;
    • Al-Kali, Aref;
    • Ashrani, Aneel A.;
    • Begna, Kebede H.;
    • Elliott, Michelle A.;
    • Hogan, William J.;
    • Hook, C. Christopher;
    • Kaufmann, Scott H.;
    • Letendre, Louis;
    • Litzow, Mark R.;
    • Patnaik, Mrinal S.;
    • Pardanani, Animesh;
    • Tefferi, Ayalew;
    • Wolanskyj, Alexandra P.;
    • Grill, Diane E.;
    • Pruthi, Rajiv K.
    Publication type:
    Article
    21

    KIT and Mastocytosis.

    Published in:
    Acta Haematologica, 2008, v. 119, n. 4, p. 194, doi. 10.1159/000140630
    By:
    • Lim, Ken-Hong;
    • Pardanani, Animesh;
    • Tefferi, Ayalew
    Publication type:
    Article
    22

    TP53 Mutations in Myeloproliferative Neoplasms: Context‐Dependent Evaluation of Prognostic Relevance.

    Published in:
    American Journal of Hematology, 2025, v. 100, n. 4, p. 552, doi. 10.1002/ajh.27609
    By:
    • Tefferi, Ayalew;
    • Abdelmagid, Maymona;
    • Loscocco, Giuseppe G.;
    • Fathima, Saubia;
    • Begna, Kebede H.;
    • Al‐Kali, Aref;
    • Foran, James;
    • Palmer, Jeanne;
    • Badar, Talha;
    • Patnaik, Mrinal M.;
    • Reichard, Kaaren K.;
    • He, Rong;
    • Zepeda Mendoza, Cinthya J.;
    • Shah, Mithun;
    • Orazi, Attilio;
    • Arber, Daniel A.;
    • Pardanani, Animesh;
    • Vannucchi, Alessandro M.;
    • Hiwase, Devendra;
    • Gangat, Naseema
    Publication type:
    Article
    23
    24

    Mayo Genetic Risk Models for Newly Diagnosed Acute Myeloid Leukemia Treated With Venetoclax + Hypomethylating Agent.

    Published in:
    American Journal of Hematology, 2025, v. 100, n. 2, p. 260, doi. 10.1002/ajh.27564
    By:
    • Gangat, Naseema;
    • Elbeih, Azeem;
    • Ghosoun, Nour;
    • McCullough, Kristen;
    • Aperna, Fnu;
    • Johnson, Isla M.;
    • Abdelmagid, Maymona;
    • Al‐Kali, Aref;
    • Alkhateeb, Hassan B.;
    • Begna, Kebede H.;
    • Elliott, Michelle;
    • Mangaonkar, Abhishek;
    • Matin, Aasiya;
    • Saliba, Antoine N.;
    • Hefazi Torghabeh, Mehrdad;
    • Litzow, Mark R.;
    • Hogan, William;
    • Shah, Mithun;
    • Patnaik, Mrinal M.;
    • Pardanani, Animesh
    Publication type:
    Article
    25

    PHF6 mutations in chronic myelomonocytic leukemia identify a unique subset of patients with distinct phenotype and superior prognosis.

    Published in:
    American Journal of Hematology, 2024, v. 99, n. 12, p. 2321, doi. 10.1002/ajh.27492
    By:
    • Tefferi, Ayalew;
    • Fathima, Saubia;
    • Alsugair, Ali Khalid A.;
    • Aperna, Fnu;
    • Natu, Anuya;
    • Abdelmagid, Maymona G.;
    • Csizmar, Clifford M.;
    • Gurney, Mark;
    • Lasho, Terra L.;
    • Finke, Christy M.;
    • Mangaonkar, Abhishek A.;
    • Al‐Kali, Aref;
    • Pardanani, Animesh;
    • Reichard, Kaaren K.;
    • He, Rong;
    • Gangat, Naseema;
    • Patnaik, Mrinal M.
    Publication type:
    Article
    26
    27
    28
    29
    30

    Venetoclax duration (14 vs. 21 vs. 28 days) in combination with hypomethylating agent in newly diagnosed acute myeloid leukemia: Comparative analysis of response, toxicity, and survival.

    Published in:
    American Journal of Hematology, 2024, v. 99, n. 2, p. E63, doi. 10.1002/ajh.27180
    By:
    • Karrar, Omer;
    • Abdelmagid, Maymona;
    • Rana, Masooma;
    • Iftikhar, Moazah;
    • McCullough, Kristen;
    • Al‐Kali, Aref;
    • Alkhateeb, Hassan B.;
    • Begna, Kebede H.;
    • Elliott, Michelle A.;
    • Mangaonkar, Abhishek;
    • Saliba, Antoine;
    • Hefazi Torghabeh, Mehrdad;
    • Litzow, Mark R.;
    • Hogan, William;
    • Shah, Mithun;
    • Patnaik, Mrinal M.;
    • Pardanani, Animesh;
    • Badar, Talha;
    • Murthy, Hemant;
    • Foran, James
    Publication type:
    Article
    31
    32

    Venetoclax and hypomethylating agent combination therapy in newly diagnosed acute myeloid leukemia: Genotype signatures for response and survival among 301 consecutive patients.

    Published in:
    American Journal of Hematology, 2024, v. 99, n. 2, p. 193, doi. 10.1002/ajh.27138
    By:
    • Gangat, Naseema;
    • Karrar, Omer;
    • Iftikhar, Moazah;
    • McCullough, Kristen;
    • Johnson, Isla M.;
    • Abdelmagid, Maymona;
    • Abdallah, Mostafa;
    • Al‐Kali, Aref;
    • Alkhateeb, Hassan B.;
    • Begna, Kebede H.;
    • Mangaonkar, Abhishek;
    • Saliba, Antoine N.;
    • Hefazi Torghabeh, Mehrdad;
    • Litzow, Mark R.;
    • Hogan, William;
    • Shah, Mithun;
    • Patnaik, Mrinal M.;
    • Pardanani, Animesh;
    • Badar, Talha;
    • Murthy, Hemant
    Publication type:
    Article
    33
    34

    Mast cell cytomorphology and treatment outcome in mast cell leukemia.

    Published in:
    American Journal of Hematology, 2024, v. 99, n. 1, p. E5, doi. 10.1002/ajh.27105
    By:
    • Tefferi, Ayalew;
    • Pardanani, Animesh;
    • Al‐Kali, Aref;
    • Alkhateeb, Hassan;
    • McCullough, Kristen;
    • Patnaik, Mrinal;
    • Hogan, William J.;
    • Begna, Kebede;
    • Elliott, Michelle A.;
    • Khera, Nandita;
    • Palmer, Jeanne M.;
    • Gangat, Naseema;
    • Kelemen, Katalin;
    • Orazi, Attilio;
    • Chen, Dong;
    • Reichard, Kaaren K.
    Publication type:
    Article
    35
    36

    A globally applicable "triple A" risk model for essential thrombocythemia based on Age, Absolute neutrophil count, and Absolute lymphocyte count.

    Published in:
    American Journal of Hematology, 2023, v. 98, n. 12, p. 1829, doi. 10.1002/ajh.27079
    By:
    • Tefferi, Ayalew;
    • Loscocco, Giuseppe G.;
    • Farrukh, Faiqa;
    • Szuber, Natasha;
    • Mannelli, Francesco;
    • Pardanani, Animesh;
    • Hanson, Curtis A.;
    • Ketterling, Rhett P.;
    • De Stefano, Valerio;
    • Carobbio, Alessandra;
    • Barbui, Tiziano;
    • Guglielmelli, Paola;
    • Gangat, Naseema;
    • Vannucchi, Alessandro M.
    Publication type:
    Article
    37

    Bortezomib and daratumumab in refractory autoimmune hemolytic anemia.

    Published in:
    American Journal of Hematology, 2023, v. 98, n. 10, p. E263, doi. 10.1002/ajh.27025
    By:
    • McGlothlin, John;
    • Abeykoon, Jithma;
    • Al‐Hattab, Eyad;
    • Ashrani, Aneel A.;
    • Elliott, Michelle;
    • Hook, C. Christopher;
    • Pardanani, Animesh;
    • Pruthi, Rajiv;
    • Sridharan, Meera;
    • Wolanskyj, Alexandra;
    • Rouse, Rachelle;
    • Go, Ronald
    Publication type:
    Article
    38
    39
    40

    TP53 mutations and variant allele frequency in myelodysplastic syndromes with del(5q): A Mayo‐Moffitt study of 156 informative cases.

    Published in:
    American Journal of Hematology, 2023, v. 98, n. 4, p. E76, doi. 10.1002/ajh.26845
    By:
    • Fleti, Farah;
    • Chan, Onyee;
    • Singh, Amritpal;
    • Abdelmagid, Maymona G.;
    • Al‐Kali, Aref;
    • Elliott, Michelle A.;
    • Begna, Kebede H.;
    • Foran, James M.;
    • Badar, Talha;
    • Khera, Nandita;
    • Al Ali, Najla H.;
    • Padron, Eric;
    • Sallman, David A.;
    • Shah, Mithun;
    • Hiwase, Devendra;
    • Pardanani, Animesh;
    • Arber, Daniel A.;
    • Orazi, Attilio;
    • Reichard, Kaaren K.;
    • He, Rong
    Publication type:
    Article
    41
    42
    43
    44
    45

    Lenalidomide therapy for primary myelodysplastic syndromes with isolated del(5q): Determinants of response and survival in a real‐world setting.

    Published in:
    American Journal of Hematology, 2022, v. 97, n. 10, p. E377, doi. 10.1002/ajh.26672
    By:
    • Singh, Amritpal;
    • Al‐Kali, Aref;
    • Foran, James M.;
    • Elliott, Michelle A.;
    • Begna, Kebede;
    • Badar, Talha;
    • Khera, Nandita;
    • Fleti, Farah;
    • Abdelmagid, Maymona;
    • Reichard, Kareen K.;
    • Ketterling, Rhett P.;
    • Pardanani, Animesh;
    • Gangat, Naseema;
    • Tefferi, Ayalew
    Publication type:
    Article
    46

    Mast cell sarcoma: 2 Mayo Clinic cases.

    Published in:
    American Journal of Hematology, 2022, v. 97, n. 10, p. 1381, doi. 10.1002/ajh.26525
    By:
    • Singh, Amritpal;
    • Alkhateeb, Hassan;
    • Pardanani, Animesh;
    • He, Rong;
    • Orazi, Attilio;
    • Tefferi, Ayalew;
    • Reichard, Kaaren K.
    Publication type:
    Article
    47

    A dynamic 3‐factor survival model for acute myeloid leukemia that accounts for response to induction chemotherapy.

    Published in:
    American Journal of Hematology, 2022, v. 97, n. 9, p. 1127, doi. 10.1002/ajh.26630
    By:
    • Tefferi, Ayalew;
    • Gangat, Naseema;
    • Al‐Kali, Aref;
    • Alkhateeb, Hassan;
    • Shah, Mithun;
    • Patnaik, Mrinal S.;
    • Elliott, Michelle A.;
    • Hogan, William J.;
    • Litzow, Mark R.;
    • Hook, Christopher C.;
    • Mangaonkar, Abhishek;
    • Viswanatha, David;
    • Chen, Dong;
    • Pardanani, Animesh;
    • Ketterling, Rhett P.;
    • DiNardo, Courtney D.;
    • Kadia, Tapan M.;
    • Ravandi, Farhad;
    • Sasaki, Koji;
    • Begna, Kebede H.
    Publication type:
    Article
    48

    Real‐world experience with venetoclax and hypomethylating agents in myelodysplastic syndromes with excess blasts.

    Published in:
    American Journal of Hematology, 2022, v. 97, n. 6, p. E214, doi. 10.1002/ajh.26539
    By:
    • Gangat, Naseema;
    • McCullough, Kristen;
    • Johnson, Isla;
    • Al‐Kali, Aref;
    • Begna, Kebede H.;
    • Patnaik, Mrinal M.;
    • Litzow, Mark R.;
    • Hogan, William;
    • Shah, Mithun;
    • Alkhateeb, Hassan;
    • Mangaonkar, Abhishek;
    • Foran, James M.;
    • Badar, Talha;
    • Palmer, Jeanne M.;
    • Sproat, Lisa;
    • Arana Yi, Cecilia Y.;
    • Pardanani, Animesh;
    • Tefferi, Ayalew
    Publication type:
    Article
    49
    50